Detailed Information on Publication Record
2020
Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye
STEPANOV, Alexandr, Martin PENCAK, Jan NEMCANSKY, Veronika MATUŠKOVÁ, Marketa STREDOVA et. al.Basic information
Original name
Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye
Name in Czech
Výsledky léčby myopických neovaskulárních ranibizumabem s ohledem na délku oka
Authors
STEPANOV, Alexandr (203 Czech Republic, guarantor), Martin PENCAK (203 Czech Republic), Jan NEMCANSKY (203 Czech Republic), Veronika MATUŠKOVÁ (203 Czech Republic, belonging to the institution), Marketa STREDOVA (203 Czech Republic), David BERAN (203 Czech Republic) and Jan STUDNICKA (203 Czech Republic)
Edition
Journal of Ophthalmology, London, Hindawi Publishing Corporation, 2020, 2090-004X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30207 Ophthalmology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.909
RIV identification code
RIV/00216224:14110/20:00115863
Organization unit
Faculty of Medicine
UT WoS
000537131400001
Keywords in English
myopic CNV; axial myopia; choroidal neovascular membrane
Tags
International impact, Reviewed
Změněno: 26/6/2020 12:40, Mgr. Tereza Miškechová
Abstract
V originále
A retrospective evaluation of the results of treatment of myopic choroidal neovascularization (mCNV) with intravitreal injections of ranibizumab in a pro re nata (PRN) regimen in three groups of patients distributed according to axial length.